or Try an Advanced Search...

    Treatment Of Breast Cancer Stocks List

    Symbol Grade Name % Change
    MACK A Merrimack Pharmaceuticals, Inc. 0.33
    NKTR A Nektar Therapeutics 1.21
    GTHX A G1 Therapeutics, Inc. 7.51
    CRIS A Curis, Inc. 3.25
    ACHV B Achieve Life Sciences, Inc. 3.76
    SLS B SELLAS Life Sciences Group, Inc. 5.47
    HOLX B Hologic, Inc. -0.49
    SNDX C Syndax Pharmaceuticals, Inc. -0.50
    CLDX C Celldex Therapeutics, Inc. 3.84
    VSTM D Verastem, Inc. 3.81
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies Software - Application
    Related Stock Lists: Breast Cancer Cancer Biopharmaceutical Medicine Clinical Medicine Ovarian Cancer Solid Tumors Cancer Cell Clinical Development Drugs Treatment Of Cancer Antineoplastic Drugs Biotechnology Cancer Research Cancer Treatment Companion Diagnostic Her2 Her2/Neu Immunology Lung Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Breast Cancer stocks.

    Symbol Grade Name Weight
    EKG C First Trust Nasdaq Lux Digital Health Solutions ETF 4.16
    MDCP D VictoryShares THB Mid Cap ESG ETF 3.25
    SBIO C ALPS Medical Breakthroughs ETF 2.86
    PBE C PowerShares Dynamic Biotech & Genome 2.8
    IHI D iShares U.S. Medical Devices ETF 2.29
    View all Treatment Of Breast Cancer ETFs...
    Compare ETFs
    Compare EKG to PBE Compare MDCP to IHI Compare PBE to IHI

        Treatment Of Breast Cancer Stocks Recent News

        Date Stock Title
        May 2 HOLX Hologic Inc. (HOLX) Surpasses Q2 Fiscal 2024 Earnings and Revenue Estimates
        May 2 HOLX Hologic (HOLX) Q2 Earnings and Revenues Beat Estimates
        May 2 HOLX Hologic Fiscal Q2 Earnings, Revenue Decline; Q3 Outlook Issued, Fiscal 2024 Estimates Revised -- Shares Up After Hours
        May 2 HOLX Hologic Non-GAAP EPS of $1.03 beats by $0.05, revenue of $1.02B beats by $20M
        May 2 HOLX Hologic Announces Financial Results for Second Quarter of Fiscal 2024
        May 2 GTHX G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call Transcript
        May 2 GTHX G1 Therapeutics Inc (GTHX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ...
        May 2 GTHX Q1 2024 G1 Therapeutics Inc Earnings Call
        May 1 HOLX Hologic Q2 2024 Earnings Preview
        May 1 GTHX G1 Therapeutics, Inc. (GTHX) Q1 2024 Earnings Call Transcript
        May 1 HOLX Will These 5 MedTech Stocks Beat Forecasts This Earnings Season?
        May 1 SLS Sellas reports positive Phase 2 data from AML study, files for patent
        May 1 SLS SELLAS Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level
        May 1 GTHX G1 Therapeutics and Pepper Bio sign license agreement for lerociclib
        May 1 GTHX G1 Therapeutics Inc (GTHX) Q1 2024 Earnings: Close Alignment with Analyst Revenue Projections
        May 1 GTHX G1 Therapeutics (GTHX) Reports Q1 Loss, Lags Revenue Estimates
        May 1 SNDX Syndax to Announce First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 8, 2024
        May 1 GTHX G1 Therapeutics reports mixed Q1 results; reaffirms FY24 outlook
        May 1 GTHX G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights
        May 1 GTHX G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies Software - Application
        Related Stock Lists: Breast Cancer Cancer Biopharmaceutical Medicine Clinical Medicine Ovarian Cancer Solid Tumors Cancer Cell Clinical Development Drugs Treatment Of Cancer Antineoplastic Drugs Biotechnology Cancer Research Cancer Treatment Companion Diagnostic Her2 Her2/Neu Immunology Lung Cancer
        Treatment Of Breast Cancer

        Treatment of breast cancer depends on the type and stage of the cancer, as well as the patient's age, overall health, and personal preferences. Treatment options may include surgery, radiation therapy, chemotherapy, hormone therapy, targeted therapy, and/or immunotherapy.

        Browse All Tags